Wellness is moving from a niche interest to a mainstream spending habit, with UK consumers directing more money toward health, fitness, and feel good experiences at festivals and beyond. As average wellness spending in the UK has risen and the wider industry now sits above £160b, some listed companies with exposure to wellness activities, retreats, and lifestyle products are drawing fresh attention. This article looks at 3 stocks that appear positively exposed to this news theme, to help you decide whether they might deserve a closer look or a place on your watchlist.
Optima Health (AIM:OPT)
Overview: Optima Health (AIM:OPT) provides occupational health and wellbeing services across the UK, helping employers in sectors like energy, transport, construction, and government support their workforces with physical and mental health programs, digital wellbeing tools, and on site assessments
Operations: Optima Health generates all of its £113.8m in revenue from providing occupational health and wellbeing services in the United Kingdom
Optima Health sits at the intersection of rising wellness spend and employer demand for preventative healthcare. Its services directly address mental health, musculoskeletal issues, and attendance management for large public and private clients. Analysts expect strong earnings and revenue growth, the company has recently moved into profitability, and the current share price is well below an estimated future cash flow value of £8.15, which has drawn attention to its valuation. At the same time, a high P/E multiple, shareholder dilution from a recent £35m equity raise, and reliance on higher risk funding sources mean investors need to weigh quality earnings against capital structure concerns and assess whether the wellness tailwind offsets these risks.
Optima Health’s wellness exposure, fresh profitability and high P/E multiple point to a story that is still being priced in, but the real tension shows up when you see the DCF valuation analysis for Optima Health
Vitalhub (TSX:VHI)
Overview: Vitalhub (TSX:VHI) develops software used by hospitals, clinics, and community care providers to manage patient flow, electronic health records, and care coordination, helping health systems run more efficiently and improve the patient journey
Operations: Vitalhub generates approximately CA$119.2m in revenue entirely from healthcare software sold to providers across Canada, the UK, Australia, Western Asia, the USA, and other regions
Market Cap: CA$462.4m
Vitalhub may appeal to investors interested in wellness because it sits behind the scenes of health systems rather than at the front of a festival yoga tent. The company supplies the software that helps hospitals and community providers run smoother patient pathways and reduce bottlenecks. Its focus on recurring, healthcare specific SaaS, combined with acquisitions that broaden its product set and geographic reach, shapes its earnings profile and profit margins. However, the stock trades only slightly below some fair value estimates. Investors may also want to consider the relatively rich P/E multiple, the integration work on recently acquired assets, and some dependence on usage based revenues, which means the quality of future growth matters as much as the headline numbers available today.
Vitalhub’s recurring healthcare software revenues and acquisition roll up approach mean there is a lot going on beneath the headline P/E. The full picture only really comes into focus in the analysis report for Vitalhub
Hydreight Technologies (TSXV:NURS)
Overview: Hydreight Technologies (TSXV:NURS) runs a digital health platform in the United States that lets people book mobile and virtual health and wellness services through an app, while also supporting practitioners with telemedicine tools, back office services, and access to an online pharmacy for treatments such as IV therapy, GLP1, NAD, Botox, and fillers
Operations: Hydreight Technologies generates CA$20.4m from Mobile Medical Services, CA$7.5m from Physical Healthcare Locations, and CA$27.8m from Virtual Healthcare, Direct To Consumer services
Market Cap: CA$256.5m
Hydreight Technologies stands out in the wellness theme because it is plugged directly into rising demand for at home and mobile care, from IV drips to GLP1 weight loss programs, through a platform that already supports services across all 50 U.S. states. The company has moved from losses to profitability, recent results show revenue and net income that compare favourably with the prior year, and analysts expect earnings and revenue growth to run well ahead of the wider market. That said, expectations are high, the business leans on higher risk external borrowing and a rich valuation, and a large share of activity is tied to peptide and GLP1 therapies, so regulatory or demand shifts could matter a lot.
Hydreight Technologies is riding surging interest in at home wellness, but the heavy tilt toward peptide and GLP1 therapies could be masking a <a href="https://todaytrendnews7.com/why-kfcs-fried-chicken-tastes-different-from-that-of-every-other-fast/” title=”Why KFC's fried chicken tastes different from that of every other fast”>different risk reward profile than headlines suggest, so it is worth reviewing the analyst forecasts for Hydreight Technologies
The three wellness focused stocks in this article are only a starting point. The full Wellness and Lifestyle Sector screener surfaces 11 more companies that pair wellness exposure with financial and business narratives that might deserve a spot on your radar. Use Simply Wall St to identify, analyze, and filter for the exact catalysts, balance sheet traits, and growth narratives that matter to you so you can focus on your highest conviction wellness and lifestyle ideas
Take Control of Your Investment Journey
If Hydreight Technologies or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point.
Once you’ve made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates.
Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives.
By uncovering hidden catalysts and risks early, you’ll accelerate your decision-making and stay one step ahead of the market.
Seeking Fresh Alternatives Beyond Wellness?
Some stock stories move from quiet to breakout fast, and the best entry points can be gone before the crowd catches on. Scan these fresh ideas now and act early
- Spot rock solid companies before momentum really starts building by checking the curated list of solid balance sheet and fundamentals (20 results) that keeps downside risk in sharper focus.
- Ride structural shifts in power and electrification with the hand picked 34 power grid technology and infrastructure stocks while these infrastructure plays are still under the radar for now.
- Target future facing automation stories by reviewing the carefully filtered 31 robotics and automation stocks before valuations move further and the easy entry points start dropping away.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it
Discover if Hydreight Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition
Access Free Analysis
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
About TSXV:NURS
Hydreight Technologies
Operates in the digital health technology sector in the United States
See The Free Research Report
High growth potential and good value
See The Free Research Report
Market Insights
What makes a lasting brand?Andrew Legget
Q-Day: The risk the market forgot to repriceRichard Bowman
Finding dividends that actually lastMitchell Lawler
Advertisement
Weekly Picks
LO
Lou_Baseneseon Giftify·3 months ago
Giftify ($GIFT): A Small-Cap Incentives Platform with More ScaleThan Its Valuation Suggests
Fair Value:US$2.563.5% undervalued
54followersusers have followed this narrative
·2commentsusers have commented on this narrative
·10likesusers have liked this narrative
HA
HarishPKon lululemon athletica·about 1 month ago
Quantifying the Transition: Why Lululemon’s Moat Remains Intact
Fair Value:US$161.826.3% undervalued
22followersusers have followed this narrative
·2commentsusers have commented on this narrative
·9likesusers have liked this narrative
TR
tripledubon Alphabet·about 1 month ago
Warren Buffett Just Bet $10 Billion on Google. The Catch? You May Already Be Too Late
Fair Value:US$23055.3% overvalued
58followersusers have followed this narrative
·1commentusers have commented on this narrative
·16likesusers have liked this narrative
JO
John_Ericon Veeva Systems·9 days ago
AI-Powered Veeva Systems Poised for Solid Growth Amid Regulatory Stability
Fair Value:US$32040.6% undervalued
32followersusers have followed this narrative
·0commentsusers have commented on this narrative
·6likesusers have liked this narrative
RecentlyUpdated Narratives
ES
Estebanon NVR·about 11 hours ago
NVR 05-2026
Fair Value:US$3.76k72.4% overvalued
2followersusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
AN
AnimalDoctorKwonon Capricor Therapeutics·about 12 hours ago
The Exosome Pioneer: Why Capricor (CAPR) is Poised for an August FDA Breakthrough
Fair Value:US$5862.9% undervalued
1followerusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
ES
Estebanon Rollins·about 12 hours ago
ROL 05-2026
Fair Value:US$16.2174.5% overvalued
2followersusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
Popular Narratives
IN
Investingwillyon Mastercard·24 days ago
Mastercard: The Best Dividend Stock You’re Ignoring
Fair Value:US$75029.8% undervalued
87followersusers have followed this narrative
·1commentusers have commented on this narrative
·9likesusers have liked this narrative
BL
BlackGoaton Cerebras Systems·20 days ago
The Wafer Giant Threatening NVIDIA’s GPU Hegemony
Fair Value:US$415.5448.2% undervalued
60followersusers have followed this narrative
·3commentsusers have commented on this narrative
·11likesusers have liked this narrative
TRtripledubon Alphabet·about 1 month ago
Warren Buffett Just Bet $10 Billion on Google. The Catch? You May Already Be Too Late
Fair Value:US$23055.3% overvalued
58followersusers have followed this narrative
·1commentusers have commented on this narrative
·16likesusers have liked this narrative
